GB9402542D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9402542D0
GB9402542D0 GB9402542A GB9402542A GB9402542D0 GB 9402542 D0 GB9402542 D0 GB 9402542D0 GB 9402542 A GB9402542 A GB 9402542A GB 9402542 A GB9402542 A GB 9402542A GB 9402542 D0 GB9402542 D0 GB 9402542D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9402542A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB9402542A priority Critical patent/GB9402542D0/en
Publication of GB9402542D0 publication Critical patent/GB9402542D0/en
Priority to JP7520951A priority patent/JPH09508637A/en
Priority to PCT/EP1995/000427 priority patent/WO1995021844A1/en
Priority to EP95909678A priority patent/EP0743946A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GB9402542A 1994-02-10 1994-02-10 Novel compounds Pending GB9402542D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB9402542A GB9402542D0 (en) 1994-02-10 1994-02-10 Novel compounds
JP7520951A JPH09508637A (en) 1994-02-10 1995-02-06 5HT2B receptor antagonist condensed indole
PCT/EP1995/000427 WO1995021844A1 (en) 1994-02-10 1995-02-06 5ht2b receptor antagonists condensed indoles
EP95909678A EP0743946A1 (en) 1994-02-10 1995-02-06 5ht2b receptor antagonists condensed indoles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9402542A GB9402542D0 (en) 1994-02-10 1994-02-10 Novel compounds

Publications (1)

Publication Number Publication Date
GB9402542D0 true GB9402542D0 (en) 1994-04-06

Family

ID=10750154

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9402542A Pending GB9402542D0 (en) 1994-02-10 1994-02-10 Novel compounds

Country Status (4)

Country Link
EP (1) EP0743946A1 (en)
JP (1) JPH09508637A (en)
GB (1) GB9402542D0 (en)
WO (1) WO1995021844A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0807104A2 (en) * 1995-02-02 1997-11-19 Smithkline Beecham Plc Heterocyclic compounds possessing 5ht 2c? receptor antagonist activity
JP2001508767A (en) * 1996-12-02 2001-07-03 藤沢薬品工業株式会社 Indole-urea derivatives having 5-HT antagonism
WO2006044762A2 (en) * 2004-10-15 2006-04-27 Bayer Pharmaceuticals Corporation Tetrahydro-5h-pyrimido[4,5-d]azepine derivatives useful for the treatment of diseases associated with the 5-ht2c receptor
KR100843352B1 (en) * 2007-01-30 2008-07-03 한국과학기술연구원 New 1,2-dihydro-1-oxophthalazinyl piperazine derivatives having biological activity on serotonin receptor 5-ht2a and 5-ht2c, and preparation thereof
KR101062376B1 (en) * 2008-04-10 2011-09-06 한국화학연구원 Novel indole carboxylic acid bispyridyl carboxamide derivatives, preparation method thereof and composition containing the same as an active ingredient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930702334A (en) * 1990-09-13 1993-09-08 데이비드 로버트 Indourea as a 5 hydroxytryptamine receptor antagonist
NZ254785A (en) * 1992-08-20 1995-09-26 Smithkline Beecham Plc Heterocyclically-condensed indoles and medicaments

Also Published As

Publication number Publication date
JPH09508637A (en) 1997-09-02
EP0743946A1 (en) 1996-11-27
WO1995021844A1 (en) 1995-08-17

Similar Documents

Publication Publication Date Title
GB9405019D0 (en) Novel compounds
GB9406498D0 (en) Novel compounds
GB9404046D0 (en) Novel compounds
EP0800389A4 (en) Novel compounds
GB9400889D0 (en) Novel compounds
GB9409718D0 (en) Novel compounds
GB9402542D0 (en) Novel compounds
GB9409717D0 (en) Novel compounds
GB9409070D0 (en) Novel compounds
GB9403317D0 (en) Novel compounds
GB9402341D0 (en) Novel compounds
GB9404043D0 (en) Novel compounds
GB9402195D0 (en) Novel compounds
GB9401549D0 (en) Novel compounds
GB9402200D0 (en) Novel compounds
GB9401511D0 (en) Novel compounds
GB9401510D0 (en) Novel compounds
GB9401139D0 (en) Novel compounds
GB9400597D0 (en) Novel compounds
GB9400592D0 (en) Novel compounds
GB9400591D0 (en) Novel compounds
GB9410781D0 (en) Novel compounds
GB9410780D0 (en) Novel compounds
GB9410506D0 (en) Novel compounds
GB9403455D0 (en) Novel compounds